Dietary and genetic probes of atherogenic dyslipidemia.
Level 5 - mechanism / opinion, no new human data
Narrative review detailing mechanistic and genetic-diet interactions without systematic methodology.
PubMed 16166563 · doi:10.1161/01.ATV.0000186365.73973.f0
What was done
Narrative review examining how dietary changes, specifically low-fat and high-carbohydrate diets, interact with genetic traits (such as APOA5 haplotypes) to modulate atherogenic dyslipidemia profiles and LDL subfraction patterns (phenotypes A and B).
What was found
The abstract reports qualitative directions of effect without numerical data. Individuals with phenotype B (predominantly small, dense LDL) experience greater reductions in LDL cholesterol, apolipoprotein B, and mid-sized LDL2 particles on low-fat, high-carbohydrate diets compared to phenotype A individuals. In contrast, low-fat diets in phenotype A individuals induce a shift from large LDL1 to small LDL3, frequently converting them to phenotype B. Additionally, an APOA5 gene haplotype associated with elevated triglycerides predicts greater diet-induced reductions in LDL2.
Why it matters
Highlights gene-diet interactions in lipoprotein subfraction distribution, supporting the concept that dietary macronutrient responses differ substantially based on an individual's baseline lipid phenotype and genetic background.
Limits
The abstract contains no quantitative metrics, effect estimates, sample sizes, or study selection criteria. Clinical cardiovascular endpoints are not reported, focusing solely on surrogate lipid subfraction changes.
Cited by
- supports High-carbohydrate diets promote hepatic VLDL particle production that leads to the atherogenic dyslipidemia phenotype: elevated triglycerides, increased small LDL, and lower HDL.